Fundraising Fox

Redshiftbio

Boxborough, US · Founded 2005 · Delaware corporation · 27 employees on LinkedIn · 2 known investors

RedShiftBio develops analytical technology that provides real-time measurement of biomolecular structure and concentration, aimed at supporting decisions in biopharmaceutical development and manufacturing.

BiotechDeep TechHardware

Founders & leadership

TO
Thomas O'LenicExecutive
EM
Eugene MaExecutive
CM
Charles MarshallExecutive

Board

FS
Frank SmithinBoard directorGeneral Partner at Technology Venture Partners
WC
William CadoganBoard director
BH
Bryson HollimonBoard directorManaging General Partner at Technology Venture Partners
WMWouter Meuleman
Wouter Meulemanin𝕏Board MemberPartner at Illumina Ventures
DB
Don BossiBoard director
SH
Susan HolleranBoard director

Investors · 2

Illumina Ventures✓ verifiedFoster City
Technology Venture Partners✓ verifiedMinneapolisvia Bryson D. Hollimon · board

Reported raises · per SEC filings

Form D private placements

$58.1M disclosed across 8 rounds · 2014–2025

▶$5.9MraisedJun 2025 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank SmithDirector
  • William CadoganDirector
  • Bryson HollimonDirector
  • Susan HolleranDirector
  • Wouter MeulemanDirector
  • Thomas O'LenicExecutive Officer, Director
Offering amount
$7.1M
Amount sold
$5.9M
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedApr 2024 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bryson HollimonDirector
  • Mark CafazzoDirector
  • William CadoganDirector
  • Wouter MeulemanDirector
  • Thomas O'LenicExecutive Officer, Director
  • Frank SmithDirector
  • Amol ChaubalDirector
Offering amount
$7M
Amount sold
$5M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedOct 2021 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles PurtellDirector
  • Julien BradleyExecutive Officer, Director
  • Bryson HollimonDirector
  • William CadoganDirector
  • Frank SmithDirector
  • Amol ChaubalDirector
Offering amount
$20M
Amount sold
$10M
Sales commissions
$275K
Placement agents
Bowen Advisors Inc.
First sale
Oct 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.4MraisedDec 2020 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles PurtellDirector
  • William CadoganDirector
  • Frank SmithDirector
  • Julien BradleyExecutive Officer, Director
  • Bryson HollimonDirector
  • Rob CarsonDirector
Offering amount
$6.4M
Amount sold
$6.4M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.3MraisedDec 2019 · 11 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • William CadoganDirector
  • Charles MarshallExecutive Officer, Director
  • Rob CarsonDirector
  • Eugene MaExecutive Officer
  • Bryson HollimanDirector
  • Frank SmithDirector
Offering amount
$18.3M
Amount sold
$18.3M
First sale
Sep 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.8MraisedMar 2017 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eugene MaExecutive Officer
  • Frank SmithDirector
  • William CadoganDirector
  • Bryson HollimanDirector
  • Charles MarshallExecutive Officer, Director
Offering amount
$10.8M
Amount sold
$10.8M
Sales commissions
$250K
Placement agents
Bowen Advisors, Inc.
First sale
Feb 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$998.1KraisedOct 2015 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank SmithDirector
  • Eugene MaExecutive Officer
  • William CadoganDirector
  • Charles MarshallExecutive Officer, Director
  • Bryson HollimonDirector
Offering amount
$2M
Amount sold
$998.1K
Minimum investment
$1
Proceeds to insiders
$50.5K
First sale
Sep 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$751.5KraisedApr 2014 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • William CadoganDirector
  • Don BossiDirector
  • Bryson HollimonDirector
  • Charles MarshallExecutive Officer, Director
  • Eugene MaExecutive Officer
Offering amount
$1.8M
Amount sold
$751.5K
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap
Oup72 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Fiveable55 shared keywordsFiveable provides AI-powered exam preparation for AP classes, offering practice questions with automated scoring and personalized study tools for high school students.
Molecular Devices49 shared keywordsMolecular Devices develops laboratory instruments and automated workflows for life science research, including SpectraMax microplate readers, high-content screening and imaging systems, colony-picking devices, and 3D organoid and cell culture solutions. It serves researchers in drug discovery, cell line development, and screening, supported by AI-enabled analysis software and GxP compliance tools.
Intechopen44 shared keywordsIntechOpen is an open-access academic publisher that publishes peer-reviewed scientific works and books across diverse fields. The platform provides researchers with tools for publishing, wider readership, and increased citation visibility.

Companies competing with Redshiftbio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Redshiftbio do?
RedShiftBio develops analytical technology that provides real-time measurement of biomolecular structure and concentration, aimed at supporting decisions in biopharmaceutical development and manufacturing.
Who are Redshiftbio's investors?
Redshiftbio's investors include Illumina Ventures, Technology Venture Partners.
How much funding has Redshiftbio raised?
Redshiftbio has disclosed $58.1M raised across 8 rounds.
Where is Redshiftbio headquartered?
Redshiftbio is headquartered in Boxborough, US.